Graft Versus Host Disease Related Dry Eye Clinical Trial
Official title:
The Prophylactic Use of Topical Cyclosporine A 0.05% (Restasis) to Prevent Onset and Progression of Graft-versus-host Disease-related Dry Eye
The purpose of this study is to determine whether Restasis is an effective treatment for preventing the occurrence and progression of dry eye syndrome in patients who have recently received a bone marrow transplant and are at risk to graft-versus-host disease.
n/a
Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention